Jiraphun Jittikoon
Overview
Explore the profile of Jiraphun Jittikoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chitpim N, Praditsitthikorn N, White L, Meeyai A, Jittikoon J, Bunwong K, et al.
PLoS One
. 2025 Mar;
20(3):e0315772.
PMID: 40029874
Conventional tuberculosis (TB) diagnosis is time-consuming, while newer molecular assays such as Xpert MTB/RIF and loop-mediated amplification test for TB (TB-LAMP) provide faster results but at a higher cost compared...
2.
Malasai K, Jittikoon J, Udomsinprasert W, Talungchit P, Youngkong S, Sangroongruangsri S, et al.
Clinicoecon Outcomes Res
. 2025 Feb;
17:33-43.
PMID: 39931251
Purpose: This study aimed to evaluate the costs and benefits of genetic testing, specifically mutation analysis and prenatal diagnostic testing, for the confirmation of thalassemia in at-risk pregnancies in Thailand,...
3.
Piriyapongsa J, Chumnumwat S, Kaewprommal P, Triparn K, Suvichapanich S, Udomsinprasert W, et al.
Sci Rep
. 2024 Dec;
14(1):30683.
PMID: 39730427
Inter-individual variability in drug responses is significantly influenced by genetic factors, underscoring the importance of population-specific pharmacogenomic studies to optimize clinical outcomes. In this study, we analyzed whole genome sequencing...
4.
Chanhom N, Sonjan J, Inchai J, Udomsinprasert W, Chaikledkaew U, Suvichapanich S, et al.
Sci Rep
. 2024 Nov;
14(1):29511.
PMID: 39604537
Nevirapine (NVP) and Efavirenz (EFV) can cause antiretroviral drug-induced liver injury (ARVDILI). The objectives of this study were to summarize and analyze existing data on pharmacogenomics associated with nonnucleoside reverse...
5.
Trachu N, Reungwetwattana T, Meanwatthana J, Sukasem C, Majam T, Saengsiwaritt W, et al.
Sci Rep
. 2024 Nov;
14(1):26543.
PMID: 39489788
This study aimed to measure relative telomere length (RTL) in blood leukocytes of advanced-stage NSCLC patients either with or without Osimertinib-induced ADRs and determine whether RTL could serve as a...
6.
Yoopetch P, Wu O, Jittikoon J, Thavorncharoensap M, Youngkong S, Praditsitthikorn N, et al.
Sci Rep
. 2024 Jul;
14(1):17693.
PMID: 39085338
Currently, interferon-gamma release assay (IGRA) is costly and not included as latent tuberculosis infection (LTBI) screening test strategy in Thailand's Universal Coverage Scheme (UCS) benefit package. The objective of this...
7.
Ungsudechachai T, Jittikoon J, Honsawek S, Udomsinprasert W
Clin Transl Sci
. 2024 Jul;
17(7):e13881.
PMID: 38982592
Chondrocyte apoptosis is recognized as one of the pathological features involved in cartilage degeneration driving the onset and progression of knee osteoarthritis (OA). This study aimed to determine the molecular...
8.
Ungsudechachai T, Honsawek S, Jittikoon J, Udomsinprasert W
Sci Rep
. 2024 Jun;
14(1):12942.
PMID: 38839908
No abstract available.
9.
Udomsinprasert W, Mookkhan N, Tabtimnark T, Aramruang T, Ungsudechachai T, Saengsiwaritt W, et al.
Bone Joint Res
. 2024 Jun;
13(6):261-271.
PMID: 38826065
Aims: This study aimed to determine the expression and clinical significance of a cartilage protein, cartilage oligomeric matrix protein (COMP), in knee osteoarthritis (OA) patients. Methods: A total of 270...
10.
Youngkong S, Kamolwat P, Wongrot P, Thavorncharoensap M, Chaikledkaew U, Nateniyom S, et al.
Sci Rep
. 2024 May;
14(1):11205.
PMID: 38755216
Tuberculosis (TB) causes an economic impact on the patients and their households. Although Thailand has expanded the national health benefit package for TB treatment, there was no data on out-of-pocket...